Elevated serum procollagen type III peptide in splanchnic and peripheral circulation of patients with inflammatory bowel disease submitted to surgery

BMC Gastroenterology

Volumn 4, Issue , 2004, Pages

  De Simone, Matilde ^a   Cioffi, Ugo ^a   Contessini Avesani, Ettore ^a   Oreggia, Barbara ^a   Paliotti, Roberta ^a   Pierini, Alberto ^a   Bolla, Gianni ^a   Oggiano, Elide ^a   Ferrero, Stefano ^a   Magrini, Fabio ^a   Ciulla, Michele M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 3;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; HUMAN; MESENTERIC VEIN; PERIPHERAL CIRCULATION; SPLANCHNIC BLOOD FLOW; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS; BLOOD; CASE CONTROL STUDY; ELBOW; MIDDLE AGED; VASCULARIZATION; VEIN;

ADULT; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLLAGEN TYPE III; CROHN DISEASE; ELBOW; HUMANS; MESENTERIC VEINS; MIDDLE AGED; SPLANCHNIC CIRCULATION; VEINS;

EID: 10444234167     PISSN: 1471230X     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-4-29     Document Type: Article

References (26)

1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205.
2. Zheng CQ, Hu GZ, Zeng ZS, Lin LJ, Gu GG. Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning. World J Gastroenterol 2003;9:1646-1656. Review.
3. Tamboli CP, Cortot A, Colombel JF. What are the major arguments in favour of the genetic susceptibility for inflammatory bowel disease? Eur J Gastroenterol Hepatol 2003;15:587-592.
4. Devani M, Cugno M, Vecchi M, Ferrero S, Di Berardino F, Avesani EC, de Franchis R, Colman RW. Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markers. Am J Gastroenterol 2002;97:2026-2032.
5. Krishnan A, Korzenik JR. Inflammatory bowel disease and environmental influences. Gastroenterol Clin North Am 2002;31:21-39.
6. Ciulla M, Cioffi U, De Simone M, Contessini-Avesani E. TGF-beta1 and collagen methabolism in IBD patients. Med Sci Monit 2002;8:LE55-56.
7. Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 2002;15:79-94 .
8. Chutkan RK. Inflammatory bowel disease. Prim Care 2001;28:539-556.
9. Harper PC, McAuliffe TL, Beeken WL. Crohn's disease in the elderly. A statistical comparison with younger patients matched for sex and duration of disease. Arch Intern Med 1986;146:753-755.
10. Oliva-Hemker M, Fiocchi C. Etiopathogenesis of inflammatory bowel disease: the importance of the pediatric perspective. Inflamm Bowel Dis 2002;8:112-128.
11. Pucilowska JB, McNaughton KK, Mohapatra NK, Hoyt EC, Zimmermann EM, Balfour Sartor R, and Kay Lund P. IGF-I and procollagen a 1 (I) are coexpressed in a subset of mesenchymal cells in active Crohn's disease. Am J Physiol Gastrointest Liver Physiol 2000;279:G1307-1322.
12. Kjeldsen J, Schaffalitzky de Muckadell OB, Junker P. Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy. Gut 1995;37:805-810.
13. Kjeldsen J, Rasmussen M, Schaffalitzky de Muckadell OB, Kronborg O, Junker P. Collagen metabolites in the peripheral and splanchnic circulation of patients with Crohn disease. Scand J Gastroenterol 2001;36:1193-1197
14. Silvennoinen J, Risteli L, Kartunen T, Risteli J. Increased degradation of type I collagen in patients with inflammatory bowel disease. Gut 1996;38:223-228.
15. Stallmach A, Schuppan D, Riese HH, Matthes H, and Riecken EO. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease. Gastroenterology 1992;102:1920-1929.
16. Hahn EG, Schuppan D. Ethanol and fibrinogenesis in the liver. In Seitz HK, Kommerell B, eds. Alcohol-related disease in gastroenterology. Berlin: Springer-Verlag, 1985, pp 124-153.
17. Uscanga L, Kennedy RH, Choux R, Drugmont M, Grimand JA, Sarles H. Sequential connective tissue matrix changes in experimental acute pancreatitis. An immunohistochemical and biochemical assessment in the rat. Int J Pancreatol 1987;2:33-45.
18. Cantin AM, Boileau R, Begin R. Increased procollagen III aminoterminal peptide related antigens and fibroblastic growth signals in the lungs of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1988;137:572-578.
19. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's disease activity index. Gastroenterology 1976;70:439-444 .
20. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report of a therapeutic trial. Br Med J 1955;(4947):1041-1048.
21. Prockop DJ, Kivirikko KI, Tuderman L, Guzman NA. The biosynthesis of collagen and its disorders. N Engl J Med 1979;301:13-23.
22. Querejeta R, Varo N, Lopez B, Larmanet M, Artinano E, Etayo JC, Martinez JL, Gutierrez-Stampa M, Emparanza JI, Gil MJ, Monreal I, Mindan JP, Diez J. Serum carboxi-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 2000;101:1729-1735.
23. Fessler JH, Fessler LI. Biosynthesis of procollagen. Annu Rev Biochem 1978;47:129-162.
24. Longobardi T, Jacobs P, Bernstein CN. Work losses related to inflammatory bowel disease in the United States: Results from the National Health Interview Survey. Am J Gastroenterol 2003;98:1064-1072.
25. Babic Z, Jagic V, Petrovic Z, Bilic A, Dinko K, Kubat G, Troskot R, Vukelic M. Elevated serum values of procollagen III peptide (PIIIP) in patients with ulcerative colitis who will develop pseudopolyps. World J Gastroenterol 2003;9:619-621.
26. Cioffi U, Ciulla MM, De Simone M, Paliotti R, Pierini A, Magrini F, Botti F, Contessini-Avesani E. Effects of chronic inflammatory bowel diseases on left ventricular structure and function: a study protocol. BMC Public Health 2002;2:19.